Retatrutide is a powerful triple agonist peptide that targets GLP-1, GIP (glucose-dependent insulinotropic polypeptide), and glucagon receptors—making it the most comprehensive metabolic peptide in its class. It builds on the progress of earlier compounds like Semaglutide and Tirzepatide by activating three key hormonal pathways involved in appetite...

Tirzepatide was originally developed to treat Type-2 diabetes but has since become a leading anti-obesity medication. It is a dual agonist of the GLP-1 and GIP receptors — meaning it activates two distinct hormonal pathways to reduce appetite, improve metabolic rate, and support sustained weight loss. For research purposes only. This product is supplied...

KPV is a tripeptide studied for its anti-inflammatory and immune-modulating properties. Used in vitro, it offers research potential in inflammation regulation, gut health, and skin regeneration, making it a valuable tool for immunology studies. For research purposes only. This product is supplied exclusively for scientific laboratory research and...